DiscoverThe Lens: Life Sciences Reinvention in FocusRethink it: Digital is not a thing, digital is a means
Rethink it: Digital is not a thing, digital is a means

Rethink it: Digital is not a thing, digital is a means

Update: 2023-02-28
Share

Description

In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital.  When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data present complex challenges, a strong digital core will fuel competitive advantages.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rethink it: Digital is not a thing, digital is a means

Rethink it: Digital is not a thing, digital is a means

Accenture